BREAST CANCER CONNECT powered by COR2ED

473 posts

BREAST CANCER CONNECT powered by COR2ED

@BreastCaConnect

COR2ED brings you Independent Medical Education developed by BREAST CANCER CONNECT, experts in Breast Cancer. https://t.co/loqcKrHH5M

Katılım Şubat 2023

356 Takip Edilen2.2K Takipçiler

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·5d

Metastatic #breastcancer (mBC) is a complex, heterogeneous disease requiring MDT collaboration 🔬 Pathologists are central to this process to ensure accurate interpretation & optimal patient management What do HCPs need to know about #biomarker testing in mBC? How can we identify/address pre-analytical phase challenges? 📹 Video podcast discussion from Prof. Gary Tse, Dr Carlos Barrios, & @OncBrothers Watch full video or listen on Spotify/Apple: cor2ed.com/precision-onco… 🤝 Endorsed by @BiomarkerCo Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedEd #BCSM #PrecisionMedicine

English

3.1K

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·27 Mar

Metastatic #breastcancer: Understanding HER2-low and -ultralow classification A novel therapeutic framework From @OncBrothers & Dr @jhaveri_komal 📜 Tap image to enlarge + view the infographic ▶️ Watch the video/listen on Spotify/Apple: cor2ed.com/breast-cancer-… Supported by an Independent Educational Grant from AstraZeneca #MedEd #OncTwitter #BCSM

BREAST CANCER CONNECT powered by COR2ED tweet media

English

1.5K

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·26 Mar

Dr Aaron Lisberg shares guidance on prophylaxis, monitoring and management of key Dato-DXd-associated adverse events, with practical infographics and a checklist to support clinical practice.

LUNG CONNECT powered by COR2ED@lung_connect

Expert guidance on prophylaxis, monitoring & management of 3 x key Dato-DXd-related AEs >> Applicable to #NSCLC & HR+/HER2- #BreastCancer 📺 From Dr Aaron Lisberg, lead author of a recent paper on this topic published in @OncJournal Watch Dr Lisberg’s video, and get the full set of infographics + a checklist for your clinical practice: cor2ed.com/lung-connect/p… 🤝 Endorsed by @WarOnCancer, @Exon20Group, @BiomarkerCo & @LungCancerEu Supported by an Independent Educational Grant from AstraZeneca. For HCPs only. #MedEd #MedTwitter #Oncology #precisionmedicine #BCSM

English

962

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·22 Mar

New video podcast! Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer 📹 From Prof. Gary Tse, Dr Carlos Barrios, & @OncBrothers Topics: -Why accurate HER2 identification and classification are so important in metastatic breast cancer -Common challenges in the pre-analytical phase that can lead to inaccurate HER2 test results -Best-practice suggestions to address challenges Endorsed by @BiomarkerCo Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

English

135

1.6K

4.5M

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·20 Mar

ADCs in HER2+ metastatic breast cancer: management of adverse events Downloadable BluePrint to use in your clinical practice! Get clear, practical strategies for managing TRAEs: N/V, fatigue, ILD From Dr @stolaney1, Prof. @Shaheenah1, Prof. @JavierCortesMD, @CarlaWhitbread, Dr Grazyna Suchodolska, & Prof. Giuseppe Curigliano Download the BluePrint & watch the expert videos 📺 for further insights: cor2ed.com/breast-cancer-… 🤝 Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca. For HCPs only. #MedEd #MedTwitter #BCSM

English

1.5K

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·17 Mar

New video podcast! Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer 📹 From Prof. Gary Tse, Dr Carlos Barrios, & @OncBrothers Topics: - Why accurate HER2 identification and classification are so important in metastatic #breastcancer - Common challenges in the pre-analytical phase that can lead to inaccurate HER2 test results - Best-practice suggestions to address challenges 🤝 Endorsed by @BiomarkerCo Watch full video or listen on Spotify/Apple: cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedEd #BCSM #PrecisionMedicine

English

611

BREAST CANCER CONNECT powered by COR2ED retweetledi

Oncology Brothers@OncBrothers·16 Mar

Her2 testing is important given bucket ✅ of TDXd! But how we test and indications for TDXd vary across multiple disease sites. Full 🗣️ on Her2 testing in #BreastCancer: ⭐️On OncBrothers & @COR2EDMedEd website ⭐️ “Oncology Brothers” podcast #bcsm #OncTwitter @OncoAlert

English

7.6K

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·15 Mar

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC ✔️ N/V ✔️ Fatigue ✔️ Interstitial lung disease (rare but critical) Downloadable BluePrint for HCPs & patients From Dr @stolaney1, Prof. @Shaheenah1, Prof. @JavierCortesMD, @CarlaWhitbread, Dr Grazyna Suchodolska, & Prof. Giuseppe Curigliano cor2ed.com/breast-cancer-… 🤝 Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca #MedEd #MedTwitter #BCSM 📺

English

461

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·13 Mar

DESTINY-Breast04 & DESTINY-Breast06 demonstrated that T-DXd provides clinically meaningful benefit in pts w/ HER2-low/-ultralow #breastcancer ✔️ HER2 assessment has shifted from a binary classification to a therapeutic continuum ✔️ Accurate HER2 scoring & recognition of its dynamic nature are now essential to identify eligible patients & optimise treatment decisions Experts @OncBrothers & Dr @jhaveri_komal discuss this topic Conversation highlights in this post 📹 Watch the full video/view the infographic/listen on Spotify/Apple: cor2ed.com/breast-cancer-… Supported by an Independent Educational Grant from AstraZeneca #MedEd #OncTwitter

English

597

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·12 Mar

📺 @CarlaWhitbread shares a patient‑focused perspective on adverse events from ADCs in HER2+ metastatic breast cancer 🔸Get clear, practical approaches to recognising and managing T-DXd-related AEs, like N/V, fatigue & ILD 🔸Download the BluePrint, featuring a 1-page factsheet to share with your pts to help them understand what to look out for and how to seek help cor2ed.com/breast-cancer-… 🤝 Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca #MedEd #MedTwitter #BCSM

English

411

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·10 Mar

ADCs in HER2+ metastatic breast cancer: management of adverse events 🔸 T-DXd is highly emetogenic 🔸 Breakthrough N/V may occur despite prophylaxis, requiring appropriate management 🔸 Fatigue associated w/ T-DXd should be proactively managed 🔸 ILD is a potentially serious AE w/ T-DXd; early detection is critical Get step-by-step guidance on best practice Downloadable BluePrint for HCPs & patients ⬇️ cor2ed.com/breast-cancer-… From Dr @stolaney1, Prof. @Shaheenah1, Prof. @JavierCortesMD, @CarlaWhitbread, Dr Grazyna Suchodolska, & Prof. Giuseppe Curigliano 🤝 Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca #MedEd #MedTwitter #BCSM 📺

English

468

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·6 Mar

Practical guidance from @BreastCaConnect on recognising and managing ADC-related toxicities in HER2+ metastatic breast cancer. As ADC use continues to expand, understanding safety profiles and proactive management strategies is increasingly important in clinical practice. #MedEd

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect

Managing ADC toxicities in HER2+ metastatic #BreastCancer: Spotlight on nausea & vomiting Dr Sara Tolaney covered this topic in a recent #MedEd video Answer the question above in this thread, then tune in to the video to see if you're correct! cor2ed.com/breast-cancer-… This educational programme is supported by an Independent Educational Grant from AstraZeneca

English

549

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·5 Mar

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC > N/V > Fatigue > Interstitial lung disease (rare but critical) From Prof. @Shaheenah1, Dr @stolaney1, Prof. @JavierCortesMD, @CarlaWhitbread, Dr Grazyna Suchodolska & Prof. Giuseppe Curigliano Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca

English

242

2.4K

7.1M

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·5 Mar

Select datopotamab deruxtecan (Dato-DXd)-associated adverse events Expert insights on prophylaxis, monitoring, and management 📺 From Dr Aaron Lisberg Download the series of infographics with a helpful checklist for your clinical practice: cor2ed.com/lung-connect/p… 🤝 Endorsed by @WarOnCancer, @Exon20Group, @BiomarkerCo & @LungCancerEu Supported by an Independent Educational Grant from AstraZeneca. For HCPs only. #MedEd #MedTwitter #Oncology #precisionmedicine #BCSM

English

330

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·2 Mar

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC ✔️ N/V ✔️ Fatigue ✔️ Interstitial lung disease (rare but critical) Downloadable BluePrint for HCPs & patients 🔗cor2ed.com/breast-cancer-… From Prof. @Shaheenah1, Dr @stolaney1, Prof. @JavierCortesMD, @CarlaWhitbread, Dr Grazyna Suchodolska, & Prof. Giuseppe Curigliano 🤝Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca #MedEd #MedTwitter #BCSM 📺

English

502

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·27 Şub

Understanding HER2-low and HER2-ultralow classification in metastatic breast cancer >> A novel therapeutic framework From @OncBrothers & Dr @jhaveri_komal Explore key trial data, 2025 CAP reporting template, when/why to perform biopsy, best practice in monitoring AEs & more! 📹 Watch the full video/view the infographic/listen on Spotify/Apple: cor2ed.com/breast-cancer-… Supported by an Independent Educational Grant from AstraZeneca #MedEd #BreastCancer

English

348

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·27 Şub

Breast Cancer Oncologists! Check out this new ADC & AEs Blueprint for a concise, evidence‑based guide that gives you a clear pathway to managing T-DXd–related adverse events in HER2+ mBC. Includes the 5‑step nausea protocol, plus the fatigue and “Five S” ILD workflow. Anticipate toxicities, prevent them where possible and intervene early. Download the paper now. #Oncology #BreastCancer #HCPTools

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect

ADCs in HER2+ metastatic breast cancer: management of adverse events Move beyond describing T-DXd toxicities as “manageable” Get clear, practical strategies for managing treatment-related adverse events ➡️ Nausea + vomiting ➡️ Fatigue ➡️ ILD From an expert panel: Dr @stolaney1, Prof. @Shaheenah1, Prof. @JavierCortesMD, @CarlaWhitbread, Dr Grazyna Suchodolska & Prof. Giuseppe Curigliano Download the BluePrint & watch the expert videos 📺 for further insights: cor2ed.com/breast-cancer-… 🤝 Endorsed by the European Oncology Nursing Society (@cancernurseEU) and @EuropaDonnaEUR Supported by an Independent Educational Grant from AstraZeneca #MedEd #MedTwitter #BCSM

English

328

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·19 Şub

Metastatic breast cancer: Med Ed resources Understanding HER2-low and HER2-ultralow classification in metastatic breast cancer >> A novel therapeutic framework From @OncBrothers & @jhaveri_komal Supported by an Independent Educational Grant from AstraZeneca

English

348

1.1M

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·17 Şub

Thank you for sharing @OncoAlert

OncoAlert@OncoAlert

JOIN COR2ED and Dr. Tolaney for Managing ADC Tox in HER2+ mBreast Cancer 👉 buff.ly/gfJbZEl Nausea and vomiting are among the most common adverse events associated with ADCs, particularly T-DXd, for patients with HER2-positive metastatic breast cancer. In this short video from COR2ED, Dr Sara Tolaney outlines a practical approach to managing nausea and vomiting, as well as other key toxicities, in clinical practice. @stolaney1

English

598

BREAST CANCER CONNECT powered by COR2ED@BreastCaConnect·13 Şub

Metastatic #breastcancer: #MedEd resources Understanding HER2-low and HER2-ultralow classification in metastatic breast cancer >> A novel therapeutic framework From @OncBrothers & @jhaveri_komal 📹 Watch the full video/listen on Spotify or Apple/view the infographic: cor2ed.com/breast-cancer-… Supported by an Independent Educational Grant from AstraZeneca #MedEd #BCSM

English

580

Keşfet

@OncBrothers @BiomarkerCo @jhaveri_komal @stolaney1 @Shaheenah1 @JavierCortesMD @CarlaWhitbread @cancernurseEU